101-79-1 4'-氯-4-氨基二苯醚
词条详情加载中…
词条详情加载中…
安全说明
运输信息:常温运输。危险描述:非危险化学品(sinopharm_reagent);WGK Germany:3,RTECS号:BX1770000,TSCA listed,危险等级:IRRITANT,海关编码:29222990,存储类别:11 - 可燃固体,危险性类别:急性毒性 类别4 经口,严重眼损伤 类别1,经皮刺激 类别2,皮肤致敏物 类别1,特异性靶器官毒性-一次接触,类别3(chemicalbook);RTECS号:BX1770000(molbase)
用途与制备
主要用于制备;可燃性危险特性:热分解排出有毒氮氧化物、氯化物烟雾;储运特性:库房低温通风干燥;灭火剂:水、二氧化碳、泡沫、干粉
医药
产率:89% 合成条件:Stage #1: With hydrazine hydrate In ethanol at 28 - 30℃; for 0.17 h; Stage #2: at 50 - 60℃; 实验步骤:通用方法:将1-取代-4-硝基苯(9.3mmol)和N₂H₄·H₂O(27.9mmol)在20ml乙醇中的混合物在28-30℃下搅拌10分钟。通过以10分钟的间隔搅拌三份,加入Raney-Ni在水(0.02g,4.41ml)中的悬浮液。30分钟后,当反应平息时,在50-60℃下继续搅拌6小时。过滤除去催化剂。蒸发溶剂,得到化合物6-10: 参考文献:[1] Green Chemistry, 2017, vol. 19, #14, p. 3400-3407;[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, #7, p. 1588-1592;[3] Journal of Medicinal Chemistry, 2013, vol. 56, #11, p. 4811-4815;[4] Pharmazie, 1980, vol. 35, #2, p. 78-80;[5] Journal of the Chemical Society, 1927, p. 1171;[6] Journal of the Chemical Society, 1929, p. 2367;[7] Bioorganic and Medicinal Chemistry, 2004, vol. 12, #16, p. 4477-4492;[8] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1978, vol. 16, p. 810-814;[9] Chemical and Pharmaceutical Bulletin, 1986, vol. 34, #2, p. 701-712;[10] Patent: US5312830, 1994, A;[11] Patent: WO2013/60029, 2013, A1;[12] Patent: WO2013/63100, 2013, A1;[13] MedChemComm, 2015, vol. 6, #4, p. 671-676;[14] European Journal of Medicinal Chemistry, 2016, vol. 113, p. 273-292;[15] Journal of Materials Chemistry A, 2018, vol. 6, #34, p. 16680-16689;[16] Chemistry - A European Journal, 2018, vol. 24, #54, p. 14418-14424;[17] Chem.Abstr., 1976, vol. 85, #20843;[18] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 9, p. 322
产率:未提供 合成条件:未提供 实验步骤:未提供 参考文献:[1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, #16, p. 4477-4492;[2] Journal of Medicinal Chemistry, 2002, vol. 45, #1, p. 219-232;[3] Journal of Medicinal Chemistry, 2013, vol. 56, #11, p. 4811-4815;[4] MedChemComm, 2015, vol. 6, #4, p. 671-676;[5] European Journal of Medicinal Chemistry, 2016, vol. 113, p. 273-292;[6] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, #7, p. 1588-1592;[7] Chem.Abstr., 1976, vol. 85, #20843
产率:未提供 合成条件:未提供 实验步骤:未提供 参考文献:[1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, #16, p. 4477-4492;[2] Journal of Medicinal Chemistry, 2002, vol. 45, #1, p. 219-232;[3] Journal of Medicinal Chemistry, 2013, vol. 56, #11, p. 4811-4815;[4] MedChemComm, 2015, vol. 6, #4, p. 671-676;[5] European Journal of Medicinal Chemistry, 2016, vol. 113, p. 273-292;[6] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, #7, p. 1588-1592